Mark Behlke

MMD, FSHD, OPMD, and some forms of EDMD and ALS, might benefit from new strategy

posted on April 18, 2009 - 9:00pm
A new gene therapy approach to "silencing" disease-causing genetic information has been developed by researchers at Rutgers University in Piscataway, N.J., and Integrated DNA Technologies in Coralville, Ia.

New content is being added every day. Please check back again.